First oral treatment for Fabry disease recommended for approval in the EU

View source ↗

Summary

The EMA recommended approval for the first oral treatment for Fabry disease in the EU, marking a potential new oral option for patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fabry Disease